よむ、つかう、まなぶ。
最終評価報告書 第３章（Ⅰ～Ⅱ4） (122 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_28410.html |
| 出典情報 | 健康日本21（第二次）最終評価報告書を公表します（10／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
PubMed PMID: 23062861.
18） Ito T, Ishigami M, Zou B, Tanaka T, Takahashi H, Kurosaki M, et al. The
epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual
and forecasting analysis, 1995-2040. Hepatol Int. 2021;15(2):366-79. Epub
20210212. doi: 10.1007/s12072-021-10143-4. PubMed PMID: 33580453.
19） Katagiri S, Nitta H, Nagasawa T, Izumi Y, Kanazawa M, Matsuo A, et al. Effect of
glycemic control on periodontitis in type 2 diabetic patients with periodontal
disease.
J
Diabetes
10.1111/jdi.12026.
Investig.
PubMed
2013;4(3):320-5.
PMID:
23997922;
Epub
PubMed
20130214.
Central
doi:
PMCID:
PMC3752968.
20） Sakane N, Kotani K, Suganuma A, et al. Effects of obesity, metabolic syndrome,
and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes
following lifestyle intervention: A subanalysis of the J-DOIT1. J Occup Health.
2020
Jan;62(1):e12109.
doi:
10.1002/1348-9585.12109.
PubMed
PMID:
32515888.
21） Sakane N. Diabetes prevention in the real world: Insights from the JDPP and JDOIT1.
J
Gen
10.1002/jgf2.85.
Fam
Med.
PubMed
2017;18(6):325-30.
PMID:
29264060;
Epub
PubMed
20171009.
Central
doi:
PMCID:
PMC5729318.
22） Hayashino Y, Suzuki H, Yamazaki K, Goto A, Izumi K, Noda M. A cluster randomized
trial on the effect of a multifaceted intervention improved the technical quality of
diabetes care by primary care physicians: The Japan Diabetes Outcome
Intervention Trial-2 (J-DOIT2). Diabet Med. 2016;33(5):599-608. Epub 20151009.
doi: 10.1111/dme.12949. PubMed PMID: 26331280; PubMed Central PMCID:
PMC5057414.
23） Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, et al. Effect of an
intensified multifactorial intervention on cardiovascular outcomes and mortality
in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet
Diabetes Endocrinol. 2017;5(12):951-64. Epub 20171024. doi: 10.1016/S22138587(17)30327-3. PubMed PMID: 29079252.
24） Christine PJ, Auchincloss AH, Bertoni AG, Carnethon MR, Sánchez BN, Moore K,
et al. Longitudinal Associations Between Neighborhood Physical and Social
Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of
Atherosclerosis
(MESA).
JAMA
Intern
Med.
2015;175(8):1311-20.
doi:
10.1001/jamainternmed.2015.2691. PubMed PMID: 26121402; PubMed Central
PMCID: PMC4799846.
25） ⽇本透析医学会．わが国の慢性透析療法の現況．
https://docs.jsdt.or.jp/overview/index.html
26） 厚⽣労働省「国⺠健康・栄養調査」
２.（３）糖尿病
144
第３章 Ⅱ
18） Ito T, Ishigami M, Zou B, Tanaka T, Takahashi H, Kurosaki M, et al. The
epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual
and forecasting analysis, 1995-2040. Hepatol Int. 2021;15(2):366-79. Epub
20210212. doi: 10.1007/s12072-021-10143-4. PubMed PMID: 33580453.
19） Katagiri S, Nitta H, Nagasawa T, Izumi Y, Kanazawa M, Matsuo A, et al. Effect of
glycemic control on periodontitis in type 2 diabetic patients with periodontal
disease.
J
Diabetes
10.1111/jdi.12026.
Investig.
PubMed
2013;4(3):320-5.
PMID:
23997922;
Epub
PubMed
20130214.
Central
doi:
PMCID:
PMC3752968.
20） Sakane N, Kotani K, Suganuma A, et al. Effects of obesity, metabolic syndrome,
and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes
following lifestyle intervention: A subanalysis of the J-DOIT1. J Occup Health.
2020
Jan;62(1):e12109.
doi:
10.1002/1348-9585.12109.
PubMed
PMID:
32515888.
21） Sakane N. Diabetes prevention in the real world: Insights from the JDPP and JDOIT1.
J
Gen
10.1002/jgf2.85.
Fam
Med.
PubMed
2017;18(6):325-30.
PMID:
29264060;
Epub
PubMed
20171009.
Central
doi:
PMCID:
PMC5729318.
22） Hayashino Y, Suzuki H, Yamazaki K, Goto A, Izumi K, Noda M. A cluster randomized
trial on the effect of a multifaceted intervention improved the technical quality of
diabetes care by primary care physicians: The Japan Diabetes Outcome
Intervention Trial-2 (J-DOIT2). Diabet Med. 2016;33(5):599-608. Epub 20151009.
doi: 10.1111/dme.12949. PubMed PMID: 26331280; PubMed Central PMCID:
PMC5057414.
23） Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, et al. Effect of an
intensified multifactorial intervention on cardiovascular outcomes and mortality
in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet
Diabetes Endocrinol. 2017;5(12):951-64. Epub 20171024. doi: 10.1016/S22138587(17)30327-3. PubMed PMID: 29079252.
24） Christine PJ, Auchincloss AH, Bertoni AG, Carnethon MR, Sánchez BN, Moore K,
et al. Longitudinal Associations Between Neighborhood Physical and Social
Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of
Atherosclerosis
(MESA).
JAMA
Intern
Med.
2015;175(8):1311-20.
doi:
10.1001/jamainternmed.2015.2691. PubMed PMID: 26121402; PubMed Central
PMCID: PMC4799846.
25） ⽇本透析医学会．わが国の慢性透析療法の現況．
https://docs.jsdt.or.jp/overview/index.html
26） 厚⽣労働省「国⺠健康・栄養調査」
２.（３）糖尿病
144
第３章 Ⅱ